May 06, 2026

Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis

Caris MI Clarity leverages AI to transform how recurrence risk is understood and applied in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer IRVING, Texas, May 5, 2026 /PRNewswire/ -- Caris Life Sciences®...

recent articles

Linköping, Sweden and Shelton, CT – International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has received a 510(k) clearance by the US Food & Drug Administration (FDA). The clearance applies for Sectra Digital...

As the pandemic outbreak is causing significant limitations in the availability of human resources across pathology departments, Inspirata is putting in action its COVID-19 Preparedness Plan, which will offer a much-needed free remote...

A Scotland-based virtual biobank dealing in ethically sourced human tissue samples is helping to speed up the provision of COVID-19 samples for researchers and drug developers working to find a cure for the global pandemic. Tissue Solutions...

Albuquerque, NM –  April 3, 2020 – Indica Labs, the leading provider of computational pathology software, is pleased to announce the formal release of its HALO AP™ Anatomic Pathology platform at NeoGenomics Laboratories, Inc. HALO...

OR

platinum partners

gold partners

Silver Partners

Media Partners